Harvest Fund Management Co. Ltd Buys Shares of 5,592 Molina Healthcare, Inc. (MOH)

Harvest Fund Management Co. Ltd bought a new position in Molina Healthcare, Inc. (NYSE:MOH) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 5,592 shares of the company’s stock, valued at approximately $832,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. FMR LLC increased its position in shares of Molina Healthcare by 85.3% during the 2nd quarter. FMR LLC now owns 4,584,133 shares of the company’s stock valued at $448,970,000 after purchasing an additional 2,110,308 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Molina Healthcare by 33.8% during the 2nd quarter. Renaissance Technologies LLC now owns 2,805,850 shares of the company’s stock valued at $274,805,000 after purchasing an additional 709,100 shares during the last quarter. Iridian Asset Management LLC CT increased its position in shares of Molina Healthcare by 10.6% during the 2nd quarter. Iridian Asset Management LLC CT now owns 1,972,634 shares of the company’s stock valued at $193,200,000 after purchasing an additional 188,902 shares during the last quarter. Acadian Asset Management LLC increased its position in shares of Molina Healthcare by 290.5% during the 3rd quarter. Acadian Asset Management LLC now owns 1,006,085 shares of the company’s stock valued at $149,607,000 after purchasing an additional 748,456 shares during the last quarter. Finally, TCW Group Inc. increased its position in shares of Molina Healthcare by 21.4% during the 2nd quarter. TCW Group Inc. now owns 882,097 shares of the company’s stock valued at $86,393,000 after purchasing an additional 155,214 shares during the last quarter.

In other Molina Healthcare news, insider James Woys acquired 25,000 shares of the company’s stock in a transaction on Wednesday, September 19th. The stock was acquired at an average price of $148.79 per share, for a total transaction of $3,719,750.00. Following the acquisition, the insider now owns 17,203 shares in the company, valued at approximately $2,559,634.37. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Norman Nichols sold 4,501 shares of the stock in a transaction that occurred on Wednesday, August 8th. The stock was sold at an average price of $127.00, for a total value of $571,627.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,717 shares of company stock worth $1,289,932. 0.65% of the stock is owned by corporate insiders.

MOH opened at $125.80 on Wednesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.38 and a current ratio of 1.38. Molina Healthcare, Inc. has a 1 year low of $66.39 and a 1 year high of $154.06. The company has a market cap of $7.88 billion, a P/E ratio of 22.95, a P/E/G ratio of 1.43 and a beta of 1.27.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Tuesday, July 31st. The company reported $3.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $1.99. Molina Healthcare had a positive return on equity of 23.01% and a negative net margin of 0.26%. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.67 billion. During the same period last year, the company earned ($4.01) EPS. Molina Healthcare’s revenue for the quarter was down 2.3% compared to the same quarter last year. Research analysts forecast that Molina Healthcare, Inc. will post 6.69 earnings per share for the current fiscal year.

Several brokerages have recently commented on MOH. Bank of America increased their price objective on Molina Healthcare from $94.00 to $110.00 and gave the company an “underperform” rating in a research report on Wednesday, August 1st. Morgan Stanley increased their price objective on Molina Healthcare from $100.00 to $108.00 and gave the company an “overweight” rating in a research report on Friday, July 13th. Jefferies Financial Group lowered Molina Healthcare from a “buy” rating to a “hold” rating and set a $152.00 price objective on the stock. in a research report on Friday, October 12th. They noted that the move was a valuation call. Wells Fargo & Co increased their price objective on Molina Healthcare from $92.00 to $120.00 and gave the company a “market perform” rating in a research report on Thursday, August 2nd. Finally, Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “buy” rating and set a $144.00 price objective on the stock in a research report on Friday, August 3rd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $130.62.

Molina Healthcare Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Recommended Story: What factors cause inflation to rise?

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply